WallStreetZenWallStreetZen

NASDAQ: NAMS
Newamsterdam Pharma Co Nv Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NAMS

Based on 7 analysts offering 12 month price targets for Newamsterdam Pharma Co Nv

Min Forecast
$37.00+23.91%
Avg Forecast
$47.00+57.4%
Max Forecast
$52.00+74.15%

Should I buy or sell NAMS stock?

Based on 7 analysts offering ratings for Newamsterdam Pharma Co Nv.

Strong Buy
Strong Buy
3 analysts 42.86%
Buy
3 analysts 42.86%
Hold
1 analysts 14.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NAMS's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates NAMS as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their NAMS stock forecasts and price targets.

NAMS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-02-19Find Out Why
lockedlocked$00.00+00.00%2026-02-18
lockedlocked$00.00+00.00%2026-01-21
lockedlocked$00.00+00.00%2025-12-16
lockedlocked$00.00+00.00%2025-12-02
HC Wainwright & Co.
Top 11%
90
BuyAssumes$52.00+74.15%2025-10-20
Citigroup
Top 12%
89
Strong BuyMaintains$50.00+67.45%2025-10-17Find out why

1 of 1

NAMS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NAMS$29.86$47.00+57.40%Strong Buy
CNTA$25.95$42.14+62.40%Strong Buy
XENE$41.94$57.40+36.86%Strong Buy
LEGN$18.97$60.00+216.29%Strong Buy
KNSA$46.16$55.50+20.23%Strong Buy
View Top Biotech Stocks

Newamsterdam Pharma Co Nv Stock Forecast FAQ

Is Newamsterdam Pharma Co Nv Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: NAMS) stock is to Strong Buy NAMS stock.

Out of 7 analysts, 3 (42.86%) are recommending NAMS as a Strong Buy, 3 (42.86%) are recommending NAMS as a Buy, 1 (14.29%) are recommending NAMS as a Hold, 0 (0%) are recommending NAMS as a Sell, and 0 (0%) are recommending NAMS as a Strong Sell.

If you're new to stock investing, here's how to buy Newamsterdam Pharma Co Nv stock.

What is NAMS's Price Target?

According to 7 Wall Street analysts that have issued a 1 year NAMS price target, the average NAMS price target is $47.00, with the highest NAMS stock price forecast at $52.00 and the lowest NAMS stock price forecast at $37.00.

On average, Wall Street analysts predict that Newamsterdam Pharma Co Nv's share price could reach $47.00 by Feb 19, 2027. The average Newamsterdam Pharma Co Nv stock price prediction forecasts a potential upside of 57.4% from the current NAMS share price of $29.86.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.